ITOS Oncology Official Launch

Media coverage from WEtech Client ITOS Oncology’s official launch party at Hotel Dieu Grace Healthcare on Wednesday, July 5th 2017.

Windsor Biomed Startup Could Become World Leader In Cancer Testing

Dr. Lisa Porter, Dr. Rasna Gupta, Dr. Sabeena Misra, Dr. Raj Atikukke, Dr. Caroline Hamm (by AM800’s Peter Langille)

Via AM800 – Peter Langille

A Windsor-based bio-med startup is leading the country in DNA sequencing for cancer diagnosis.

ITOS Oncology is based in a space at Hotel Dieu Grace Healthcare.

They use specialized equipment to sequence DNA at a level of detail only found in research labs in Canada.

Company Founder Dr. Govindaraja (Raj) Atikukke says there’s only one other centre in North America offering this kind of testing commercially.

Windsor on cutting edge of cancer treatment research

Dr. Raj Atikukke, the founder of ITOS Oncology, uses molecular diagnostic technology to study cancer biopsies looking for DNA mutations that can help pinpoint specific types of cancer. (Meg Roberts/CBC)

Via CBC Windsor

A Windsor biomedical company is rolling out cutting-edge cancer-fighting technology that uses DNA sequencing to precisely identify and combat the disease in individual patients.

Leading the research is Dr. Raj Atikukke, the founder of ITOS Oncology, who uses molecular diagnostic technology to study cancer biopsies looking for DNA mutations.

Those mutations in a person’s genetic road map tell Atikukke the specific form of cancer he’s looking at, which then allows for a more precise, less harmful treatment.

“You don’t have to use a cocktail of different chemotherapy, you can use one targeted drug in a patient,” Atikukke said during a presentation of his work Wednesday morning.

New Windsor company aims to personalize cancer treatment

Raj Atikkuke, a molecular medicine and genetics researcher and founder of ITOS Oncology, speaks to reporters following a media event discussing the latest cancer research technology at Hotel-Dieu Grace Healthcare, July 5, 2017. Dax Melmer / Windsor Star

Via Windsor Star – Ann Jarvis, Published on: July 5, 2017

Bladder cancer progresses quickly in some patients but not in others. Why? The answer is probably in the cancer cell genes.

Somewhere in each cancer cell are genes that have mutated. If those genes and their mutations can be identified, they can be targeted with treatment that is more effective and has fewer side-effects.

It’s personalized cancer treatment.

Windsor company using cutting edge technology to personalize cancer treatment

Govindaraja (Raj) Atikukke, chief technological officer and founder of ITOS Oncology, explains how next generation sequencing technology works inside his lab space at Hotel-Dieu Grace Healtcare’s Tayfour Campus July 5, 2017. – Tom Morrison

Via Our WindsorBy Tom Morrison

A Windsor company is partnering with researchers by using its DNA sequencing technology to determine ways to personalize treatments for cancer patients.

ITOS Oncology is now operating out of Hotel-Dieu Grace Healthcare’s Tayfour Campus. Founded by Govindaraja (Raj) Atikukke, the company has the only next generation sequencing technology between Windsor and London.

The equipment can determine which DNA from a cancer biopsy is susceptible to mutations and have researchers and clinicians use that information towards care for individual treatment or drug development.

Local Company Helping to Target Cancer at its roots

Photo by Mike Kovaliv Photography

Via Snapd WindsorPhotos by Mike Kovaliv Photography

ITOS held a special media event at the Ken Lewenza Sr. Lobby, Hôtel-Dieu Grace Healthcare to not only explain what their research means for cancer patients in Windsor/Essex but also the future of cancer research today. ITOS held a special media event at the Ken Lewenza Sr. Lobby, Hôtel-Dieu Grace Healthcare to not only explain what their research means for cancer patients in Windsor/Essex but also the future of cancer research today.

‘Game-changing technology’ is coming to Windsor

Via CTV Windsor

Print Friendly, PDF & Email